|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print July 26, 2002
Am J Physiol Lung Cell Mol Physiol, 10.1152/ajplung.00231.2001
Submitted on June 18, 2001
Accepted on July 22, 2002
1 Physiology Program, Harvard School of Public Health, Boston, MA, USA
2 Pulmonary and Critical Care Division, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
* To whom correspondence should be addressed. E-mail: sshore{at}hsph.harvard.edu.
IL-1ß inhibits isoproterenol (ISO) induced relaxation of cultured human airway smooth muscle (HASM) cells. The purpose of this study was to determine whether IL-1ß can also suppress ISO-induced cAMP response element (CRE) dependent gene expression. ISO (10 µM) caused a marked increase in CRE-binding protein (CREB) phosphorylation which was attenuated by IL-1ß(2ng/ml). This effect of IL-1ß was abolished by the COX inhibitor indomethacin. To examine CRE driven gene expression, we transiently transfected HASM cells with a construct containing CRE elements upstream of a luciferase reporter gene. ISO (6h) caused a 6-fold increase in luciferase activity. IL-1ß(24h) alone also increased luciferase activity, though to a lesser extent (2-fold). However the ability of ISO to elicit luciferase expression was marked reduced in cells treated with IL-1ß. The MEK and p38 inhibitors, U0126 and SB203580, the COX inhibitor indomethacin, the PKA inhibitor H-89, and the glucocorticoid dexamethasone, each completely abolished the ability of IL-1ß to induce CRE driven gene expression, but only slightly increased the ability of ISO to induce CRE driven gene expression in IL-1ß treated cells. IL-1ß also attenuated db cAMP induced CRE driven gene expression, but not db cAMP induced CREB phosphorylation. TNF
(10 ng/ml) also attenuated ISO-induced CRE driven gene expression, even though it was without effect on ISO-induced cAMP formation or ISO-induced CREB phosphorylation. The results suggest that IL-1ß and TNF
may attenuate the ability of ß-agonists to induce expression of genes with CRE elements in their regulatory regions, through events downstream of PKA.
This article has been cited by other articles:
![]() |
A. M. Goldsmith, M. B. Hershenson, M. P. Wolbert, and J. K. Bentley Regulation of airway smooth muscle {alpha}-actin expression by glucocorticoids Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L99 - L106. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Faffe, L. Flynt, M. Mellema, T. R. Whitehead, K. Bourgeois, R. A. Panettieri Jr., E. S. Silverman, and S. A. Shore Oncostatin M causes VEGF release from human airway smooth muscle: synergy with IL-1{beta} Am J Physiol Lung Cell Mol Physiol, June 1, 2005; 288(6): L1040 - L1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Chen, O. Tliba, C. R. Van Besien, R. A. Panettieri Jr., and Y. Amrani Selected Contribution: TNF-{alpha} modulates murine tracheal rings responsiveness to G-protein-coupled receptor agonists and KCl J Appl Physiol, August 1, 2003; 95(2): 864 - 872. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |